Oxcarbazepine and Hepatocellular injury - a phase IV clinical study of FDA data
Summary:
Hepatocellular injury is found among people who take Oxcarbazepine, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Oxcarbazepine and have Hepatocellular injury. It is created by eHealthMe based on reports of 10,768 people who have side effects when taking Oxcarbazepine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10,768 people reported to have side effects when taking Oxcarbazepine.
Among them, 14 people (0.13%) have Hepatocellular injury.
What is Oxcarbazepine?
Oxcarbazepine has active ingredients of oxcarbazepine. It is often used in epilepsy. eHealthMe is studying from 11,198 Oxcarbazepine users for its effectiveness, alternative drugs and more.
What is Hepatocellular injury?
Hepatocellular injury (liver injury) is found to be associated with 958 drugs and 882 conditions by eHealthMe.
Number of Oxcarbazepine and Hepatocellular injury reports submitted per year:

Time on Oxcarbazepine when people have Hepatocellular injury *:
- < 1 month: 66.67 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 33.33 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Hepatocellular injury when taking Oxcarbazepine *:
- female: 76.92 %
- male: 23.08 %
Age of people who have Hepatocellular injury when taking Oxcarbazepine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 7.69 %
- 50-59: 84.62 %
- 60+: 7.69 %
Common drugs people take besides Oxcarbazepine *:
- Paracetamol: 10 people, 71.43%
- Zemuron: 1 person, 7.14%
- Vitamin E: 1 person, 7.14%
- Versed: 1 person, 7.14%
- Trileptal: 1 person, 7.14%
- Sevoflurane: 1 person, 7.14%
- Saw Palmetto: 1 person, 7.14%
- Ginseng: 1 person, 7.14%
- Fentanyl: 1 person, 7.14%
- Cefazolin: 1 person, 7.14%
Common side effects people have besides Hepatocellular injury *:
- Fatigue (feeling of tiredness): 6 people, 42.86%
- Abdominal Pain Upper: 6 people, 42.86%
- Nausea And Vomiting: 1 person, 7.14%
- Nausea (feeling of having an urge to vomit): 1 person, 7.14%
- Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 1 person, 7.14%
- Itching: 1 person, 7.14%
- Headache (pain in head): 1 person, 7.14%
- Gallbladder Disorder: 1 person, 7.14%
- Faeces Discolored: 1 person, 7.14%
- Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 1 person, 7.14%
Common conditions people have *:
- Depression: 8 people, 57.14%
- Pain: 2 people, 14.29%
- Viral Infection: 1 person, 7.14%
- Lipids Abnormal: 1 person, 7.14%
- Bleeding Disorders: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Oxcarbazepine and have Hepatocellular injury?
Check whether Hepatocellular injury is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Hepatocellular injury and when was it recovered:
Expand to all the drugs that have ingredients of oxcarbazepine:
Alternative drugs to, pros and cons of Oxcarbazepine:
- Oxcarbazepine (11,198 reports)
Common Oxcarbazepine side effects:
- Abdominal pain: 104 reports
- Abnormal behavior: 117 reports
- Abortion spontaneous (naturally occurring miscarriage): 146 reports
- Acute kidney failure: 132 reports
- Aggression: 223 reports
- Agitation (state of anxiety or nervous excitement): 186 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 110 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 149 reports
- Arrhythmias (irregular heartbeat): 141 reports
- Back pain: 103 reports
- Balance disorder: 195 reports
- Breathing difficulty: 196 reports
- Cardiac arrest: 114 reports
- Chest pain: 146 reports
- Completed suicide (act of taking one's own life): 399 reports
- Confusional state: 218 reports
- Constipation: 127 reports
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 549 reports
- Cough: 103 reports
- Death: 144 reports
- Depression: 304 reports
- Diarrhea: 265 reports
- Diplopia (double vision): 154 reports
- Disturbance in attention: 105 reports
- Dizziness: 568 reports
- Drowsiness: 433 reports
- Drug hypersensitivity: 138 reports
- Drug ineffective: 1,124 reports
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 287 reports
- Erythema multiforme (a type of hypersensitivity reaction): 106 reports
- Fall: 433 reports
- Fatigue (feeling of tiredness): 547 reports
- Fever: 333 reports
- Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 117 reports
- Gait disturbance: 223 reports
- Headache (pain in head): 438 reports
- Head injury: 112 reports
- High blood pressure: 212 reports
- Hypoaesthesia (reduced sense of touch or sensation): 102 reports
- Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 398 reports
- Hypotension (abnormally low blood pressure): 138 reports
- Insomnia (sleeplessness): 244 reports
- Irritability: 109 reports
- Itching: 147 reports
- Joint pain: 152 reports
- Loss of consciousness: 146 reports
- Malaise (a feeling of general discomfort or uneasiness): 224 reports
- Maternal exposure during pregnancy (use of substance during pregnancy): 146 reports
- Memory loss: 268 reports
- Movement - uncoordinated: 128 reports
- Muscle spasms (muscle contraction): 129 reports
- Nausea (feeling of having an urge to vomit): 367 reports
- Nausea and vomiting: 369 reports
- Overdose: 151 reports
- Pain: 315 reports
- Pain in extremity: 165 reports
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 132 reports
- Pneumonia: 128 reports
- Psychotic disorder: 120 reports
- Rashes (redness): 396 reports
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 880 reports
- Speech disorder: 118 reports
- Speech impairment (adult) (inability to speak (adult)): 140 reports
- Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 163 reports
- Stress and anxiety: 339 reports
- Suicidal ideation: 174 reports
- Suicide attempt: 103 reports
- Thrombocytopenia (decrease of platelets in blood): 104 reports
- Tremor (trembling or shaking movements in one or more parts of your body): 238 reports
- Urinary tract infection: 128 reports
- Weakness: 331 reports
- Weight decreased: 182 reports
- Weight increased: 241 reports
Browse all side effects of Oxcarbazepine:
a b c d e f g h i j k l m n o p q r s t u v w x y zHepatocellular injury treatments and more:
- Hepatocellular injury (14,296 reports)
COVID vaccines that are related to Hepatocellular injury:
- Hepatocellular injury in Moderna COVID Vaccine
- Hepatocellular injury in Pfizer BioNTech Covid Vaccine
- Hepatocellular injury in Johnson and Johnson Covid Vaccine
Common drugs associated with Hepatocellular injury:
- Acetaminophen: 128 reports
- Aldactone: 122 reports
- Allopurinol: 339 reports
- Alprazolam: 302 reports
- Amlodipine: 315 reports
- Amoxicillin: 341 reports
- Aspirin: 220 reports
- Atarax: 142 reports
- Atenolol: 105 reports
- Atorvastatin calcium: 135 reports
- Augmentin: 458 reports
- Bactrim: 678 reports
- Carboplatin: 169 reports
- Cefotaxime: 140 reports
- Ceftriaxone: 248 reports
- Cellcept: 128 reports
- Clarithromycin: 120 reports
- Cordarone: 191 reports
- Crestor: 276 reports
- Cyclophosphamide: 227 reports
- Cymbalta: 146 reports
- Cytarabine: 216 reports
- Dexamethasone: 126 reports
- Diazepam: 138 reports
- Eliquis: 167 reports
- Emend: 154 reports
- Escitalopram: 146 reports
- Etoposide: 112 reports
- Flagyl: 137 reports
- Fluconazole: 109 reports
- Furosemide: 439 reports
- Gaviscon: 119 reports
- Gilenya: 122 reports
- Hydrochlorothiazide: 125 reports
- Ibuprofen: 206 reports
- Innohep: 199 reports
- Irbesartan: 126 reports
- Isentress: 133 reports
- Kaletra: 141 reports
- Keppra: 274 reports
- Keytruda: 108 reports
- Lamictal: 167 reports
- Lansoprazole: 432 reports
- Lantus: 154 reports
- Levetiracetam: 184 reports
- Lovenox: 605 reports
- Lyrica: 399 reports
- Metformin: 392 reports
- Methotrexate: 849 reports
- Methotrexate sodium: 101 reports
- Metronidazole: 113 reports
- Mirtazapine: 119 reports
- Morphine: 227 reports
- Movicol: 147 reports
- Neurontin: 101 reports
- Nexium: 189 reports
- Norvir: 207 reports
- Novorapid: 123 reports
- Olanzapine: 193 reports
- Omeprazole: 351 reports
- Ondansetron: 132 reports
- Opdivo: 114 reports
- Oxaliplatin: 179 reports
- Oxycontin: 139 reports
- Paclitaxel: 137 reports
- Pantoprazole: 625 reports
- Paracetamol: 1,978 reports
- Paroxetine: 188 reports
- Plaquenil: 113 reports
- Plavix: 153 reports
- Polaramine: 120 reports
- Prednisolone: 224 reports
- Prednisone: 369 reports
- Prezista: 148 reports
- Ramipril: 313 reports
- Risperidone: 130 reports
- Sertraline: 155 reports
- Simvastatin: 192 reports
- Solu-medrol: 182 reports
- Spironolactone: 107 reports
- Tacrolimus: 123 reports
- Tegretol: 112 reports
- Tramadol: 450 reports
- Tramadol hydrochloride: 116 reports
- Truvada: 184 reports
- Valium: 134 reports
- Xanax: 222 reports
- Xarelto: 127 reports
- Zolpidem: 139 reports
- Zopiclone: 214 reports
All the drugs that are associated with Hepatocellular injury:
- Hepatocellular injury (958 drugs)
Common conditions associated with Hepatocellular injury:
- Acute lymphoblastic anemia: 352 reports
- Acute lymphocytic leukemia (all): 355 reports
- A-fib: 325 reports
- Ankylosing spondylitis: 120 reports
- Anxiety: 348 reports
- Atrial fibrillation: 339 reports
- Atrial fibrillation/flutter: 339 reports
- Bipolar disorder: 103 reports
- Blood pressure - high: 1,000 reports
- Blood triglycerides increased: 356 reports
- Breast cancer: 240 reports
- Breast cancer metastatic: 126 reports
- Cardiac failure: 107 reports
- Cystitis: 134 reports
- Depression: 713 reports
- Diabetes: 179 reports
- Diabetes - type 2: 301 reports
- Dyslipidemia: 367 reports
- Epilepsy: 345 reports
- Feeling uptight: 348 reports
- Gastroesophageal reflux disease: 167 reports
- High blood cholesterol: 340 reports
- High blood pressure: 951 reports
- Hiv: 362 reports
- Hiv infection: 374 reports
- Human immunodeficiency virus infection: 362 reports
- Hypercholesterolaemia: 340 reports
- Hypertension: 951 reports
- Hypertension aggravated: 1,040 reports
- Infection: 445 reports
- Insomnia: 180 reports
- Lipid profile: 111 reports
- Lipid test: 367 reports
- Low thyroid: 199 reports
- Lung adenocarcinoma: 128 reports
- Lung disorder: 160 reports
- Metastatic malignant melanoma: 110 reports
- Multiple sclerosis: 202 reports
- Nausea and vomiting: 115 reports
- Neuralgia: 111 reports
- Pain: 1,165 reports
- Pain management: 1,084 reports
- Preventive health care: 173 reports
- Reflux esophagitis: 174 reports
- Rheumatoid arthritis: 304 reports
- Spondylitis: 120 reports
- Tuberculosis: 106 reports
All the conditions that are associated with Hepatocellular injury:
- Hepatocellular injury (882 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on oxcarbazepine (the active ingredients of Oxcarbazepine) and Oxcarbazepine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lidocaine Viscous and Confusional State - 3 seconds ago
- Accupril and Flat Affect - 5 seconds ago
- Stomatitis and Retinal Vascular Thrombosis - 10 seconds ago
- Fibrosis and Renal Impairment - 11 seconds ago
- Lasix vs. Celebrex - 20 seconds ago
- Tramadol Hydrochloride and Emphysema - 21 seconds ago
- Norvasc and Zebeta drug interaction - 23 seconds ago
- Imdur and Olanzapine drug interaction - 30 seconds ago
- Westcort and Cough - 37 seconds ago
- Dexedrine and Rexulti drug interaction - 37 seconds ago